Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S0066-782X2012005000022 http://repositorio.unifesp.br/handle/11600/7047 |
Resumo: | BACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal stenting (BMS). OBJECTIVE: This study aims to assess the impact of BMS and the effect of oral sirolimus on endothelial function. METHODS: Forty-five patients were randomized into three groups: BMS + high-dose oral sirolimus (initial dose of 15 mg, followed by 6 mg/day for four weeks); BMS + low-dose sirolimus (6 mg followed by 2 mg daily for four weeks); and BMS without sirolimus. Changes in vasoconstriction or vasodilation in a 15 mm segment starting at the distal stent end in response to acetylcholine and nitroglycerin were assessed by quantitative angiography. RESULTS: The groups had similar angiographic characteristics. The percent variation in diameter in response to acetylcholine was similar in all groups at the two time points (p = 0.469). Four hours after stenting, the target segment presented an endothelial dysfunction that was maintained after eight months in all groups. In all groups, endothelium-independent vasomotion in response to nitroglycerin was similar at four hours and eight months, with increased target segment diameter after nitroglycerin infusion (p = 0.001). CONCLUSION: The endothelial dysfunction was similarly present at the 15 mm segment distal to the treated segment, at 4 hours and 8 months after stenting. Sirolimus administered orally during 4 weeks to prevent restenosis did not affect the status of endothelium-dependent and independent vasomotion. |
id |
UFSP_df640eac7906d849c2f5f25a92b2c040 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/7047 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelioImpact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotionStentscoronary vesselsendotheliumsirolimusStentsvasos coronarianosendotéliosirolimusBACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal stenting (BMS). OBJECTIVE: This study aims to assess the impact of BMS and the effect of oral sirolimus on endothelial function. METHODS: Forty-five patients were randomized into three groups: BMS + high-dose oral sirolimus (initial dose of 15 mg, followed by 6 mg/day for four weeks); BMS + low-dose sirolimus (6 mg followed by 2 mg daily for four weeks); and BMS without sirolimus. Changes in vasoconstriction or vasodilation in a 15 mm segment starting at the distal stent end in response to acetylcholine and nitroglycerin were assessed by quantitative angiography. RESULTS: The groups had similar angiographic characteristics. The percent variation in diameter in response to acetylcholine was similar in all groups at the two time points (p = 0.469). Four hours after stenting, the target segment presented an endothelial dysfunction that was maintained after eight months in all groups. In all groups, endothelium-independent vasomotion in response to nitroglycerin was similar at four hours and eight months, with increased target segment diameter after nitroglycerin infusion (p = 0.001). CONCLUSION: The endothelial dysfunction was similarly present at the 15 mm segment distal to the treated segment, at 4 hours and 8 months after stenting. Sirolimus administered orally during 4 weeks to prevent restenosis did not affect the status of endothelium-dependent and independent vasomotion.FUNDAMENTO: Não há consenso sobre o impacto do implante de stent sobre a função endotelial no longo prazo. Há relatos de disfunção endotelial aumentada com stent com sirolimus quando comparado com o stent metálico convencional (BMS). OBJETIVO: Este estudo visa a avaliar o impacto do BMS e o efeito do sirolimus por via oral sobre a função endotelial. MÉTODOS: Quarenta e cinco pacientes foram randomizados em três grupos: BMS + altas doses de sirolimus oral (dose inicial de 15 mg, seguida de 6 mg/dia durante quatro semanas); BMS + baixa dose de sirolimus (6 mg, seguida de 2 mg por dia durante quatro semanas) e BMS sem sirolimus. Mudanças na vasoconstrição ou vasodilatação, em um segmento de 15 milímetros começando pelo extremo distal do stent em resposta a acetilcolina e nitroglicerina, foram avaliadas por angiografia quantitativa. RESULTADOS: Os grupos apresentaram características angiográficas semelhantes. A variação percentual de diâmetro em resposta a acetilcolina foi semelhante em todos os grupos, nos dois momentos (p = 0,469). Quatro horas após o implante de stent, o segmento alvo apresentou uma disfunção endotelial que se manteve após oito meses em todos os grupos. Em todos os grupos, a vasomotricidade independente de endotélio em resposta a nitroglicerina foi semelhante, às quatro horas e aos oito meses, com diâmetro do segmento alvo aumentado após a infusão de nitroglicerina (p = 0,001). CONCLUSÃO: A disfunção endotelial esteve igualmente presente no segmento distal de 15 milímetros do segmento tratado, às 4 horas e aos 8 meses após implante do stent. O sirolimus administrado por via oral durante quatro semanas para evitar a reestenose não afetou o estado de vasomotricidade endotélio dependente e independente.Universidade Federal de São Paulo (UNIFESP) Hospital do Rim e HipertensãoUNIFESP, Hospital do Rim e HipertensãoSciELOSociedade Brasileira de Cardiologia - SBCUniversidade Federal de São Paulo (UNIFESP)Fernandes, Rósley Weber Alvarenga [UNIFESP]Dantas, João Miguel [UNIFESP]Oliveira, Dinaldo Cavalcanti [UNIFESP]Bezerra, Hiram Grando [UNIFESP]Brito Jr., Fabio Sandoli [UNIFESP]Lima, Valter C. [UNIFESP]2015-06-14T13:43:41Z2015-06-14T13:43:41Z2012-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion290-299application/pdfapplication/pdfhttp://dx.doi.org/10.1590/S0066-782X2012005000022Arquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 98, n. 4, p. 290-299, 2012.10.1590/S0066-782X2012005000022S0066-782X2012000400002-en.pdfS0066-782X2012000400002-es.pdfS0066-782X2012000400002-pt.pdf0066-782XS0066-782X2012000400002http://repositorio.unifesp.br/handle/11600/7047WOS:000305765200006porArquivos Brasileiros de Cardiologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T04:47:38Zoai:repositorio.unifesp.br/:11600/7047Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T04:47:38Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion |
title |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio |
spellingShingle |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio Fernandes, Rósley Weber Alvarenga [UNIFESP] Stents coronary vessels endothelium sirolimus Stents vasos coronarianos endotélio sirolimus |
title_short |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio |
title_full |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio |
title_fullStr |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio |
title_full_unstemmed |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio |
title_sort |
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio |
author |
Fernandes, Rósley Weber Alvarenga [UNIFESP] |
author_facet |
Fernandes, Rósley Weber Alvarenga [UNIFESP] Dantas, João Miguel [UNIFESP] Oliveira, Dinaldo Cavalcanti [UNIFESP] Bezerra, Hiram Grando [UNIFESP] Brito Jr., Fabio Sandoli [UNIFESP] Lima, Valter C. [UNIFESP] |
author_role |
author |
author2 |
Dantas, João Miguel [UNIFESP] Oliveira, Dinaldo Cavalcanti [UNIFESP] Bezerra, Hiram Grando [UNIFESP] Brito Jr., Fabio Sandoli [UNIFESP] Lima, Valter C. [UNIFESP] |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Fernandes, Rósley Weber Alvarenga [UNIFESP] Dantas, João Miguel [UNIFESP] Oliveira, Dinaldo Cavalcanti [UNIFESP] Bezerra, Hiram Grando [UNIFESP] Brito Jr., Fabio Sandoli [UNIFESP] Lima, Valter C. [UNIFESP] |
dc.subject.por.fl_str_mv |
Stents coronary vessels endothelium sirolimus Stents vasos coronarianos endotélio sirolimus |
topic |
Stents coronary vessels endothelium sirolimus Stents vasos coronarianos endotélio sirolimus |
description |
BACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal stenting (BMS). OBJECTIVE: This study aims to assess the impact of BMS and the effect of oral sirolimus on endothelial function. METHODS: Forty-five patients were randomized into three groups: BMS + high-dose oral sirolimus (initial dose of 15 mg, followed by 6 mg/day for four weeks); BMS + low-dose sirolimus (6 mg followed by 2 mg daily for four weeks); and BMS without sirolimus. Changes in vasoconstriction or vasodilation in a 15 mm segment starting at the distal stent end in response to acetylcholine and nitroglycerin were assessed by quantitative angiography. RESULTS: The groups had similar angiographic characteristics. The percent variation in diameter in response to acetylcholine was similar in all groups at the two time points (p = 0.469). Four hours after stenting, the target segment presented an endothelial dysfunction that was maintained after eight months in all groups. In all groups, endothelium-independent vasomotion in response to nitroglycerin was similar at four hours and eight months, with increased target segment diameter after nitroglycerin infusion (p = 0.001). CONCLUSION: The endothelial dysfunction was similarly present at the 15 mm segment distal to the treated segment, at 4 hours and 8 months after stenting. Sirolimus administered orally during 4 weeks to prevent restenosis did not affect the status of endothelium-dependent and independent vasomotion. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-04-01 2015-06-14T13:43:41Z 2015-06-14T13:43:41Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0066-782X2012005000022 Arquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 98, n. 4, p. 290-299, 2012. 10.1590/S0066-782X2012005000022 S0066-782X2012000400002-en.pdf S0066-782X2012000400002-es.pdf S0066-782X2012000400002-pt.pdf 0066-782X S0066-782X2012000400002 http://repositorio.unifesp.br/handle/11600/7047 WOS:000305765200006 |
url |
http://dx.doi.org/10.1590/S0066-782X2012005000022 http://repositorio.unifesp.br/handle/11600/7047 |
identifier_str_mv |
Arquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 98, n. 4, p. 290-299, 2012. 10.1590/S0066-782X2012005000022 S0066-782X2012000400002-en.pdf S0066-782X2012000400002-es.pdf S0066-782X2012000400002-pt.pdf 0066-782X S0066-782X2012000400002 WOS:000305765200006 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Arquivos Brasileiros de Cardiologia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
290-299 application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cardiologia - SBC |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cardiologia - SBC |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268302078246912 |